{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:42:28Z","timestamp":1791848548141,"version":"4.3.4"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100019091","name":"Key Research and Development Program of Hunan Province of China","doi-asserted-by":"publisher","award":["2024JK2111"],"award-info":[{"award-number":["2024JK2111"]}],"id":[{"id":"10.13039\/501100019091","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-025-02458-9","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T12:33:00Z","timestamp":1759408380000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Microbiome-metabolome interplay in pancreatic cancer progression: insights from multi-omics analysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Dong","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qizhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongguang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liandong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"2458_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2458_CR2","doi-asserted-by":"publisher","first-page":"e214708","DOI":"10.1001\/jamanetworkopen.2021.4708","volume":"4","author":"L Rahib","year":"2021","unstructured":"Rahib L, Wehner MR, Matrisian LM, Nead KT. Estimated projection of US cancer incidence and death to 2040. JAMA Netw Open. 2021;4:e214708.","journal-title":"JAMA Netw Open"},{"key":"2458_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41571-018-0112-1","volume":"16","author":"O Strobel","year":"2019","unstructured":"Strobel O, Neoptolemos J, J\u00e4ger D, B\u00fcchler MW. Optimizing the outcomes of pancreatic cancer surgery. Nat Rev Clin Oncol. 2019;16:11\u201326.","journal-title":"Nat Rev Clin Oncol"},{"key":"2458_CR4","unstructured":"Xu J. China Anti-Cancer Association guidelines for the holistic integrative management of pancreatic cancer (abridged version). Chin J Clin Oncol 2023; 50:487-496."},{"key":"2458_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102338","volume":"104","author":"MI Meneses-Medina","year":"2022","unstructured":"Meneses-Medina MI, Gervaso L, Cella CA, Pellicori S, Gandini S, Sousa MJ, et al. Chemotherapy in pancreatic ductal adenocarcinoma: when cytoreduction is the aim. A systematic review and meta-analysis. Cancer Treat Rev. 2022;104:102338.","journal-title":"Cancer Treat Rev"},{"key":"2458_CR6","doi-asserted-by":"publisher","first-page":"e073995","DOI":"10.1136\/bmj-2022-073995","volume":"383","author":"M Del Chiaro","year":"2023","unstructured":"Del Chiaro M, Sugawara T, Karam SD, Messersmith WA. Advances in the management of pancreatic cancer. BMJ. 2023;383:e073995.","journal-title":"BMJ"},{"key":"2458_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-031621-024600","volume":"18","author":"MH Sherman","year":"2023","unstructured":"Sherman MH, Beatty GL. Tumor microenvironment in pancreatic cancer pathogenesis and therapeutic resistance. Annu Rev Pathol. 2023;18:123\u201348.","journal-title":"Annu Rev Pathol"},{"key":"2458_CR8","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1200\/JCO.21.02616","volume":"40","author":"NA Ullman","year":"2022","unstructured":"Ullman NA, Burchard PR, Dunne RF, Linehan DC. Immunologic strategies in pancreatic cancer: making cold tumors hot. J Clin Oncol. 2022;40:2789\u2013805.","journal-title":"J Clin Oncol"},{"key":"2458_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111798","volume":"141","author":"X Hao","year":"2021","unstructured":"Hao X, Ren Y, Feng M, Wang Q, Wang Y. Metabolic reprogramming due to hypoxia in pancreatic cancer: implications for tumor formation, immunity, and more. Biomed Pharmacother. 2021;141:111798.","journal-title":"Biomed Pharmacother"},{"key":"2458_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216649","volume":"587","author":"J Ren","year":"2024","unstructured":"Ren J, Ren B, Liu X, Cui M, Fang Y, Wang X, et al. Crosstalk between metabolic remodeling and epigenetic reprogramming: a new perspective on pancreatic cancer. Cancer Lett. 2024;587:216649.","journal-title":"Cancer Lett"},{"key":"2458_CR11","volume":"1878","author":"YF Meng","year":"2023","unstructured":"Meng YF, Fan ZY, Zhou B, Zhan HX. Role of the intratumoral microbiome in tumor progression and therapeutics implications. Biochimica et Biophysica Acta (BBA). 2023;1878:189014.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"2458_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1029033","volume":"12","author":"JT Huang","year":"2022","unstructured":"Huang JT, Mao YQ. The impact of the microbiome in cancer: targeting metabolism of cancer cells and host. Front Oncol. 2022;12:1029033.","journal-title":"Front Oncol"},{"key":"2458_CR13","doi-asserted-by":"publisher","first-page":"572492","DOI":"10.3389\/fcimb.2020.572492","volume":"10","author":"Q Li","year":"2020","unstructured":"Li Q, Jin M, Liu Y, Jin L. Gut microbiota: its potential roles in pancreatic cancer. Front Cell Infect Microbiol. 2020;10:572492.","journal-title":"Front Cell Infect Microbiol"},{"key":"2458_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12943-019-1008-0","volume":"18","author":"MY Wei","year":"2019","unstructured":"Wei MY, Shi S, Liang C, Meng QC, Hua J, Zhang YY, et al. The microbiota and microbiome in pancreatic cancer: more influential than expected. Mol Cancer. 2019;18:97.","journal-title":"Mol Cancer"},{"key":"2458_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.216031","volume":"554","author":"Z Jiang","year":"2023","unstructured":"Jiang Z, Zhang W, Zhang Z, Sha G, Wang D, Tang D. Intratumoral microbiota: a new force in diagnosing and treating pancreatic cancer. Cancer Lett. 2023;554:216031.","journal-title":"Cancer Lett"},{"key":"2458_CR16","doi-asserted-by":"publisher","first-page":"6070","DOI":"10.1097\/JS9.0000000000000877","volume":"110","author":"VJ Picozzi","year":"2024","unstructured":"Picozzi VJ. Pancreatic cancer: new approaches to drug therapy. Int J Surg. 2024;110:6070\u201380.","journal-title":"Int J Surg"},{"key":"2458_CR17","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1097\/JS9.0000000000002242","volume":"111","author":"Z Rong","year":"2025","unstructured":"Rong Z, Yang J, Liu J, Meng Q, Hua J, Tan Z, et al. Dense stroma activates the TGF-beta1\/FBW7 axis to induce metabolic subtype switching in pancreatic cancer. Int J Surg. 2025;111:1891\u2013903.","journal-title":"Int J Surg"},{"key":"2458_CR18","doi-asserted-by":"publisher","first-page":"S1497","DOI":"10.1016\/j.annonc.2024.10.269","volume":"35","author":"D Luo","year":"2024","unstructured":"Luo D, Li Y, Ji L, Gong X. 249P the intratumoral metabolic characterization and potential mechanisms in pancreatic ductal adenocarcinoma. Ann Oncol. 2024;35:S1497.","journal-title":"Ann Oncol"},{"key":"2458_CR19","volume":"1878","author":"S Fu","year":"2023","unstructured":"Fu S, Xu S, Zhang S. The role of amino acid metabolism alterations in pancreatic cancer: from mechanism to application. Biochimica et Biophysica Acta (BBA). 2023;1878:188893.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"795\u2013806","key":"2458_CR20","first-page":"e712","volume":"178","author":"E Riquelme","year":"2019","unstructured":"Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, Dong W, et al. Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell. 2019;178(795\u2013806):e712.","journal-title":"Cell"},{"key":"2458_CR21","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1158\/2159-8290.CD-17-1134","volume":"8","author":"S Pushalkar","year":"2018","unstructured":"Pushalkar S, Hundeyin M, Daley D, Zambirinis CP, Kurz E, Mishra A, et al. The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression. Cancer Discov. 2018;8:403\u201316.","journal-title":"Cancer Discov"},{"key":"2458_CR22","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.ccell.2022.09.009","volume":"40","author":"B Ghaddar","year":"2022","unstructured":"Ghaddar B, Biswas A, Harris C, Omary MB, Carpizo DR, Blaser MJ, et al. Tumor microbiome links cellular programs and immunity in pancreatic cancer. Cancer Cell. 2022;40:1240-1253.e1245.","journal-title":"Cancer Cell"},{"key":"2458_CR23","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1158\/0008-5472.CAN-16-2929","volume":"77","author":"S Thomas","year":"2017","unstructured":"Thomas S, Izard J, Walsh E, Batich K, Chongsathidkiet P, Clarke G, et al. The host microbiome regulates and maintains human health: a primer and perspective for non-microbiologists. Cancer Res. 2017;77:1783\u2013812.","journal-title":"Cancer Res"},{"key":"2458_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01693-0","volume":"9","author":"Y Cao","year":"2024","unstructured":"Cao Y, Xia H, Tan X, Shi C, Ma Y, Meng D, et al. Intratumoural microbiota: a new frontier in cancer development and therapy. Signal Transduct Target Ther. 2024;9:15.","journal-title":"Signal Transduct Target Ther"},{"key":"2458_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01159-9","volume":"7","author":"C Xue","year":"2022","unstructured":"Xue C, Jia J, Gu X, Zhou L, Lu J, Zheng Q, et al. Intratumoral bacteria interact with metabolites and genetic alterations in hepatocellular carcinoma. Signal Transduct Target Ther. 2022;7:335.","journal-title":"Signal Transduct Target Ther"},{"key":"2458_CR26","doi-asserted-by":"publisher","first-page":"30751","DOI":"10.1038\/srep30751","volume":"6","author":"TJ Hieken","year":"2016","unstructured":"Hieken TJ, Chen J, Hoskin TL, Walther-Antonio M, Johnson S, Ramaker S, et al. The microbiome of aseptically collected human breast tissue in benign and malignant disease. Sci Rep. 2016;6:30751.","journal-title":"Sci Rep"},{"key":"2458_CR27","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41421-024-00746-0","volume":"10","author":"L Yuan","year":"2024","unstructured":"Yuan L, Pan L, Wang Y, Zhao J, Fang L, Zhou Y, et al. Characterization of the landscape of the intratumoral microbiota reveals that Streptococcus anginosus increases the risk of gastric cancer initiation and progression. Cell Discov. 2024;10:117.","journal-title":"Cell Discov"},{"key":"2458_CR28","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.ebiom.2019.04.028","volume":"44","author":"ZE Ilhan","year":"2019","unstructured":"Ilhan ZE, \u0141aniewski P, Thomas N, Roe DJ, Chase DM, Herbst-Kralovetz MM. Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling. EBioMedicine. 2019;44:675\u201390.","journal-title":"EBioMedicine"},{"key":"2458_CR29","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41586-023-05728-y","volume":"615","author":"J Tintelnot","year":"2023","unstructured":"Tintelnot J, Xu Y, Lesker TR, Sch\u00f6nlein M, Konczalla L, Giannou AD, et al. Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature. 2023;615:168\u201374.","journal-title":"Nature"},{"key":"2458_CR30","doi-asserted-by":"publisher","first-page":"e0096224","DOI":"10.1128\/spectrum.00962-24","volume":"12","author":"Y Fang","year":"2024","unstructured":"Fang Y, Liu X, Ren J, Wang X, Zhou F, Huang S, et al. Integrated analysis of microbiome and metabolome reveals signatures in PDAC tumorigenesis and prognosis. Microbiol Spectr. 2024;12:e0096224.","journal-title":"Microbiol Spectr"},{"key":"2458_CR31","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.ccell.2022.08.011","volume":"40","author":"D Akhoundova","year":"2022","unstructured":"Akhoundova D, Rubin MA. Clinical application of advanced multi-omics tumor profiling: shaping precision oncology of the future. Cancer Cell. 2022;40:920\u201338.","journal-title":"Cancer Cell"},{"key":"2458_CR32","doi-asserted-by":"publisher","first-page":"433","DOI":"10.14348\/molcells.2021.0042","volume":"44","author":"YJ Heo","year":"2021","unstructured":"Heo YJ, Hwa C, Lee GH, Park JM, An JY. Integrative multi-omics approaches in cancer research: from biological networks to clinical subtypes. Mol Cells. 2021;44:433\u201343.","journal-title":"Mol Cells"},{"key":"2458_CR33","doi-asserted-by":"publisher","first-page":"2166700","DOI":"10.1080\/19490976.2023.2166700","volume":"15","author":"Z Zhu","year":"2023","unstructured":"Zhu Z, Cai J, Hou W, Xu K, Wu X, Song Y, et al. Microbiome and spatially resolved metabolomics analysis reveal the anticancer role of gut Akkermansia muciniphila by crosstalk with intratumoral microbiota and reprogramming tumoral metabolism in mice. Gut Microbes. 2023;15:2166700.","journal-title":"Gut Microbes"},{"key":"2458_CR34","doi-asserted-by":"publisher","first-page":"e0045724","DOI":"10.1128\/msystems.00457-24","volume":"10","author":"T Li","year":"2025","unstructured":"Li T, Zhao Z, Peng M, Zhang L, Wang C, Luo F, et al. Multi-omics analysis reveals the interplay between intratumoral bacteria and glioma. mSystems. 2025;10:e0045724.","journal-title":"mSystems"},{"key":"2458_CR35","doi-asserted-by":"publisher","first-page":"e2105523","DOI":"10.1002\/advs.202105523","volume":"9","author":"F Kong","year":"2022","unstructured":"Kong F, Fang C, Zhang Y, Duan L, Du D, Xu G, et al. Abundance and metabolism disruptions of intratumoral microbiota by chemical and physical actions unfreeze tumor treatment resistance. Adv Sci. 2022;9:e2105523.","journal-title":"Adv Sci"},{"key":"2458_CR36","first-page":"565","volume":"47","author":"R Kand\u2019\u00e1r","year":"2009","unstructured":"Kand\u2019\u00e1r R, Z\u00e1kov\u00e1 P, Jirosov\u00e1 J, Sladk\u00e1 M. Determination of branched chain amino acids, methionine, phenylalanine, tyrosine and alpha-keto acids in plasma and dried blood samples using HPLC with fluorescence detection. Clin Chem Lab Med. 2009;47:565\u201372.","journal-title":"Clin Chem Lab Med"},{"key":"2458_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00179","volume":"10","author":"SP Walker","year":"2020","unstructured":"Walker SP, Tangney M, Claesson MJ. Sequence-based characterization of intratumoral bacteria-a guide to best practice. Front Oncol. 2020;10:179.","journal-title":"Front Oncol"},{"key":"2458_CR38","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41586-022-05435-0","volume":"611","author":"JL Galeano Ni\u00f1o","year":"2022","unstructured":"Galeano Ni\u00f1o JL, Wu H, LaCourse KD, Kempchinsky AG, Baryiames A, Barber B, et al. Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer. Nature. 2022;611:810\u20137.","journal-title":"Nature"},{"key":"2458_CR39","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.aay9189","volume":"368","author":"D Nejman","year":"2020","unstructured":"Nejman D, Livyatan I, Fuks G, Gavert N, Zwang Y, Geller LT, et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science. 2020;368:973\u201380.","journal-title":"Science"},{"key":"2458_CR40","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aah5043","volume":"357","author":"LT Geller","year":"2017","unstructured":"Geller LT, Barzily-Rokni M, Danino T, Jonas OH, Shental N, Nejman D, et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 2017;357:1156\u201360.","journal-title":"Science"},{"key":"2458_CR41","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","volume":"178","author":"E Riquelme","year":"2019","unstructured":"Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, Dong W, et al. Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes. Cell. 2019;178:795-806.e712.","journal-title":"Cell"},{"key":"2458_CR42","first-page":"131","volume":"21","author":"A Taglialegna","year":"2023","unstructured":"Taglialegna A. Pseudomonas against cancer. Nat Rev Microbiol. 2023;21:131.","journal-title":"Nat Rev Microbiol"},{"key":"2458_CR43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s42003-022-04395-5","volume":"6","author":"JK Choi","year":"2023","unstructured":"Choi JK, Naffouje SA, Goto M, Wang J, Christov K, Rademacher DJ, et al. Cross-talk between cancer and Pseudomonas aeruginosa mediates tumor suppression. Commun Biol. 2023;6:16.","journal-title":"Commun Biol"},{"key":"2458_CR44","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.molmed.2024.03.008","volume":"30","author":"MC De Santis","year":"2024","unstructured":"De Santis MC, Bockorny B, Hirsch E, Cappello P, Martini M. Exploiting pancreatic cancer metabolism: challenges and opportunities. Trends Mol Med. 2024;30:592\u2013604.","journal-title":"Trends Mol Med"},{"key":"2458_CR45","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41419-024-06930-0","volume":"15","author":"H Wu","year":"2024","unstructured":"Wu H, Fu M, Wu M, Cao Z, Zhang Q, Liu Z. Emerging mechanisms and promising approaches in pancreatic cancer metabolism. Cell Death Dis. 2024;15:553.","journal-title":"Cell Death Dis"},{"key":"2458_CR46","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s43018-023-00647-3","volume":"5","author":"J Encarnaci\u00f3n-Rosado","year":"2024","unstructured":"Encarnaci\u00f3n-Rosado J, Sohn ASW, Biancur DE, Lin EY, Osorio-Vasquez V, Rodrick T, et al. Targeting pancreatic cancer metabolic dependencies through glutamine antagonism. Nat Cancer. 2024;5:85\u201399.","journal-title":"Nat Cancer"},{"key":"2458_CR47","doi-asserted-by":"publisher","first-page":"175883592412849","DOI":"10.1177\/17588359241284911","volume":"16","author":"AJ Ouissam","year":"2024","unstructured":"Ouissam AJ, Hind C, Sami Aziz B, Said A. Inhibition of the PI3K\/AKT\/mTOR pathway in pancreatic cancer: is it a worthwhile endeavor? Ther Adv Med Oncol. 2024;16:17588359241284912.","journal-title":"Ther Adv Med Oncol"},{"key":"2458_CR48","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature12040","volume":"496","author":"J Son","year":"2013","unstructured":"Son J, Lyssiotis CA, Ying H, Wang X, Hua S, Ligorio M, et al. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature. 2013;496:101\u20135.","journal-title":"Nature"},{"key":"2458_CR49","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41417-021-00326-4","volume":"29","author":"T Suzuki","year":"2022","unstructured":"Suzuki T, Kishikawa T, Sato T, Takeda N, Sugiura Y, Seimiya T, et al. Mutant KRAS drives metabolic reprogramming and autophagic flux in premalignant pancreatic cells. Cancer Gene Ther. 2022;29:505\u201318.","journal-title":"Cancer Gene Ther"},{"key":"2458_CR50","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1158\/2159-8290.CD-17-0952","volume":"8","author":"A Yang","year":"2018","unstructured":"Yang A, Herter-Sprie G, Zhang H, Lin EY, Biancur D, Wang X, et al. Autophagy sustains pancreatic cancer growth through both cell-autonomous and nonautonomous mechanisms. Cancer Discov. 2018;8:276\u201387.","journal-title":"Cancer Discov"},{"key":"2458_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.773665","volume":"11","author":"Z Pang","year":"2021","unstructured":"Pang Z, Xu Y, Zhu Q. Early growth response 1 suppresses macrophage phagocytosis by inhibiting NRF2 activation through upregulation of autophagy during Pseudomonas aeruginosa infection. Front Cell Infect Microbiol. 2021;11:773665.","journal-title":"Front Cell Infect Microbiol"},{"key":"2458_CR52","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s40364-023-00544-y","volume":"11","author":"D de Miguel-Perez","year":"2023","unstructured":"de Miguel-Perez D, Ortega FG, Tejada RG, Mart\u00ednez-\u00danica A, Peterson CB, Russo A, et al. Baseline extracellular vesicle miRNA-30c and autophagic CTCs predict chemoradiotherapy resistance and outcomes in patients with lung cancer. Biomark Res. 2023;11:98.","journal-title":"Biomark Res"},{"key":"2458_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2023.106422","volume":"185","author":"X Zheng","year":"2023","unstructured":"Zheng X, Fang Y, Zou X, Wang X, Li Z. Therapeutic potential of Pseudomonas aeruginosa-mannose sensitive hemagglutinin (PA-MSHA) in cancer treatment. Microb Pathog. 2023;185:106422.","journal-title":"Microb Pathog"},{"key":"2458_CR54","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1053\/j.gastro.2023.05.036","volume":"165","author":"S Yousuf","year":"2023","unstructured":"Yousuf S, Qiu M, Voith von Voithenberg L, Hulkkonen J, Macinkovic I, Schulz AR, et al. Spatially Resolved Multi-Omics Single-Cell Analyses Inform Mechanisms of Immune Dysfunction in Pancreatic Cancer. Gastroenterology. 2023;165:891-908.e814.","journal-title":"Gastroenterology"},{"key":"2458_CR55","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.ccell.2023.09.012","volume":"41","author":"LE Colbert","year":"2023","unstructured":"Colbert LE, El Alam MB, Wang R, Karpinets T, Lo D, Lynn EJ, et al. Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring. Cancer Cell. 2023;41:1945-1962.e1911.","journal-title":"Cancer Cell"},{"key":"2458_CR56","doi-asserted-by":"publisher","first-page":"7135","DOI":"10.1038\/s41467-023-42788-0","volume":"14","author":"L Ning","year":"2023","unstructured":"Ning L, Zhou YL, Sun H, Zhang Y, Shen C, Wang Z, et al. Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts. Nat Commun. 2023;14:7135.","journal-title":"Nat Commun"},{"key":"2458_CR57","doi-asserted-by":"publisher","first-page":"2269623","DOI":"10.1080\/19490976.2023.2269623","volume":"15","author":"K Mima","year":"2023","unstructured":"Mima K, Hamada T, Inamura K, Baba H, Ugai T, Ogino S. The microbiome and rise of early-onset cancers: knowledge gaps and research opportunities. Gut Microbes. 2023;15:2269623.","journal-title":"Gut Microbes"},{"key":"2458_CR58","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/ijc.33877","volume":"150","author":"S Wang","year":"2022","unstructured":"Wang S, Li M, Yan L, He M, Lin H, Xu Y, et al. Metabolomics study reveals systematic metabolic dysregulation and early detection markers associated with incident pancreatic cancer. Int J Cancer. 2022;150:1091\u2013100.","journal-title":"Int J Cancer"},{"key":"2458_CR59","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2022.5383","author":"M Zuz\u010d\u00e1k","year":"2022","unstructured":"Zuz\u010d\u00e1k M, Trnka J. Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment (Review). Int J Oncol. 2022. https:\/\/doi.org\/10.3892\/ijo.2022.5383.","journal-title":"Int J Oncol"},{"key":"2458_CR60","doi-asserted-by":"publisher","first-page":"5041","DOI":"10.1002\/cam4.3870","volume":"10","author":"C Mohindroo","year":"2021","unstructured":"Mohindroo C, Hasanov M, Rogers JE, Dong W, Prakash LR, Baydogan S, et al. Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients. Cancer Med. 2021;10:5041\u201350.","journal-title":"Cancer Med"},{"key":"2458_CR61","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1126\/science.aar6918","volume":"359","author":"L Zitvogel","year":"2018","unstructured":"Zitvogel L, Ma Y, Raoult D, Kroemer G, Gajewski TF. The microbiome in cancer immunotherapy: diagnostic tools and therapeutic strategies. Science. 2018;359:1366\u201370.","journal-title":"Science"},{"key":"2458_CR62","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41568-021-00418-1","volume":"22","author":"AA Connor","year":"2022","unstructured":"Connor AA, Gallinger S. Pancreatic cancer evolution and heterogeneity: integrating omics and clinical data. Nat Rev Cancer. 2022;22:131\u201342.","journal-title":"Nat Rev Cancer"},{"key":"2458_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092346","author":"JY Jeong","year":"2020","unstructured":"Jeong JY, Kim TB, Kim J, Choi HW, Kim EJ, Yoo HJ, et al. Diversity in the extracellular vesicle-derived microbiome of tissues according to tumor progression in pancreatic cancer. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12092346.","journal-title":"Cancers (Basel)"},{"key":"2458_CR64","doi-asserted-by":"publisher","first-page":"2073785","DOI":"10.1080\/19490976.2022.2073785","volume":"14","author":"Q Tan","year":"2022","unstructured":"Tan Q, Ma X, Yang B, Liu Y, Xie Y, Wang X, et al. Periodontitis pathogen Porphyromonas gingivalis promotes pancreatic tumorigenesis via neutrophil elastase from tumor-associated neutrophils. Gut Microbes. 2022;14:2073785.","journal-title":"Gut Microbes"},{"key":"2458_CR65","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1093\/carcin\/bgy073","volume":"39","author":"RM Thomas","year":"2018","unstructured":"Thomas RM, Gharaibeh RZ, Gauthier J, Beveridge M, Pope JL, Guijarro MV, et al. Intestinal microbiota enhances pancreatic carcinogenesis in preclinical models. Carcinogenesis. 2018;39:1068\u201378.","journal-title":"Carcinogenesis"},{"key":"2458_CR66","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.1038\/s41467-019-13036-1","volume":"10","author":"JS Johnson","year":"2019","unstructured":"Johnson JS, Spakowicz DJ, Hong BY, Petersen LM, Demkowicz P, Chen L, et al. Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis. Nat Commun. 2019;10:5029.","journal-title":"Nat Commun"},{"key":"2458_CR67","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41586-023-06583-7","volume":"622","author":"GA Pavlopoulos","year":"2023","unstructured":"Pavlopoulos GA, Baltoumas FA, Liu S, Selvitopi O, Camargo AP, Nayfach S, et al. Unraveling the functional dark matter through global metagenomics. Nature. 2023;622:594\u2013602.","journal-title":"Nature"},{"key":"2458_CR68","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1016\/j.csbj.2024.04.060","volume":"23","author":"E Aplakidou","year":"2024","unstructured":"Aplakidou E, Vergoulidis N, Chasapi M, Venetsianou NK, Kokoli M, Panagiotopoulou E, et al. Visualizing metagenomic and metatranscriptomic data: a comprehensive review. Comput Struct Biotechnol J. 2024;23:2011\u201333.","journal-title":"Comput Struct Biotechnol J"},{"key":"2458_CR69","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.73","volume":"2","author":"N Zhang","year":"2023","unstructured":"Zhang N, Kandalai S, Zhou X, Hossain F, Zheng Q. Applying multi-omics toward tumor microbiome research. Imeta. 2023;2:e73.","journal-title":"Imeta"},{"key":"2458_CR70","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s40168-018-0605-2","volume":"6","author":"NM Davis","year":"2018","unstructured":"Davis NM, Proctor DM, Holmes SP, Relman DA, Callahan BJ. Simple statistical identification and removal of contaminant sequences in marker-gene and metagenomics data. Microbiome. 2018;6:226.","journal-title":"Microbiome"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02458-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-025-02458-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02458-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T14:03:10Z","timestamp":1759413790000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-025-02458-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2458"],"URL":"https:\/\/doi.org\/10.1186\/s12943-025-02458-9","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"17 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the studies were conducted in accordance with recognized ethical guidelines (e.g., Declaration of Helsinki, CIOMS, Belmont Report, U.S. CommonRule) and tissue and clinical information were used after approval from the Ethics Committee of Xiangya hospital of Central South University (2025081285), which approved the patient consent forms or waiver of consent. Pancreatic cancer samples were provided by the Biobank of Xiangya Hospital, Central South University, which has been accredited by China National Accreditation Service for Conformity Assessment (CNAS). The collection, storage, and use of samples were in accordance with ISO 20387: 2018 Biotechnology-Biobanking-General Requirements for Biobanking (CNAS-CL10 Accreditation Criteria for the Quality and Competence of Biobank).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"240"}}